APA

Oei A. L., van Leeuwen C. M., Ahire V. R., Rodermond H. M., Ten Cate R., Westermann A. M., Stalpers L. J. A., Crezee J., Kok H. P., Krawczyk P. M., Kanaar R. & Franken N. A. P. (20180305). Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia. : Oncotarget.

Chicago

Oei Arlene L, van Leeuwen Caspar M, Ahire Vidhula R, Rodermond Hans M, Ten Cate Rosemarie, Westermann Anneke M, Stalpers Lukas J A, Crezee Johannes, Kok H Petra, Krawczyk Przemek M, Kanaar Roland and Franken Nicolaas A P. 20180305. Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia. : Oncotarget.

Harvard

Oei A. L., van Leeuwen C. M., Ahire V. R., Rodermond H. M., Ten Cate R., Westermann A. M., Stalpers L. J. A., Crezee J., Kok H. P., Krawczyk P. M., Kanaar R. and Franken N. A. P. (20180305). Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia. : Oncotarget.

MLA

Oei Arlene L, van Leeuwen Caspar M, Ahire Vidhula R, Rodermond Hans M, Ten Cate Rosemarie, Westermann Anneke M, Stalpers Lukas J A, Crezee Johannes, Kok H Petra, Krawczyk Przemek M, Kanaar Roland and Franken Nicolaas A P. Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia. : Oncotarget. 20180305.